Cargando…
Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism
PURPOSE: Cyclooxygenase (COX) is the main pharmacodynamic target of nonsteroidal anti-inflammatory drugs (NSAIDs). We investigated the inhibitory effects on COX-2 after NSAIDs administration using a lipopolysaccharide (LPS)-derived COX-2 induction model in whole blood, according to the genotypes of...
Autores principales: | Lee, Sook Joung, Park, Min Kyu, Shin, Dong-Seong, Chun, Min Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604555/ https://www.ncbi.nlm.nih.gov/pubmed/29066864 http://dx.doi.org/10.2147/DDDT.S143807 |
Ejemplares similares
-
Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk
por: Shen, Jing, et al.
Publicado: (2006) -
Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients
por: Malskat, Wendy SJ, et al.
Publicado: (2013) -
Cross-reactivity to Acetaminophen and Celecoxib According to the Type of Nonsteroidal Anti-inflammatory Drug Hypersensitivity
por: Kim, Yoon-Jeong, et al.
Publicado: (2014) -
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010) -
Nonsteroidal anti‐inflammatory drugs and pharyngitis
por: Mazzone, Stuart B, et al.
Publicado: (2022)